Literature DB >> 11590469

[Impact of pterygium size on corneal topography and visual acuity - a prospective clinical cross-sectional study].

B Seitz1, A Gütay, M Küchle, M M Kus, A Langenbucher.   

Abstract

PURPOSE: Pterygia may cause topographic changes featuring increase of astigmatism. The purpose of this study was to quantify the impact of the head-limbus-distance (=height) and limbal base length of the pterygium on the anterior corneal curvature and visual acuity before excision. PATIENTS AND METHODS: In 52 eyes (19 female, 33 male) with a mean age of 53 +/- 14 years the pterygium size (height, base length, area) was quantified using projected preoperative clinical slides and was correlated with visual acuity, refractive, keratometric, topographic astigmatism and Surface Regularity Index (SRI), Surface Asymmetry Index (SAI) of the TMS-1 videokeratoscope.
RESULTS: The mean height of the pterygium was 3.1 +/- 1.4 (0.8 to 6.7) mm, the mean base length was 5.1 +/- 1.4 (2.9 to 7.8) mm, the estimated mean area was 11.4 +/- 6.9 (2.1 to 29.4) mm(2). The increasing pterygium height and area resulted in a highly significant elevation of the preoperative SRI and SAI values (p </= 0.01). The amount of keratometric (p=0.02) and topographic astigmatism (p=0.001) correlated significantly with height and area of the pterygium. In addition, pterygium size correlated significantly with the differences of zonal corneal power between steepest and flattest hemimeridian in the 3-mm zone or 5-mm zone, respectively (p </= 0.01). Best-corrected visual acuity and height/area of the pterygium correlated significantly inversely (p=0.001). Visual acuity seemed to be mostly unaffected up to a height of 2.5 mm. Overall, the impact of the base length was much less striking. Topographic astigmatism (3.3 +/- 2.8 D) was significantly larger than keratometric astigmatism (2.1 +/- 2.1 D) (p=0.001). The larger the pterygium, the larger was the difference between keratometric astigmatism and subjectively tolerated spectacle cylinder (p </= 0.01).
CONCLUSIONS: Increasing distance of the pterygium head from the limbus results in increased amount and irregularity of preoperatively induced corneal astigmatism. This may explain the patient's decrease in visual acuity before the pterygium reaches the optical axis. Our data may help to determine the adequate time point for primary pterygium excision.

Entities:  

Mesh:

Year:  2001        PMID: 11590469     DOI: 10.1055/s-2001-17639

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  5 in total

Review 1.  [Application of wavefront analysis in clinical and scientific settings. From irregular astigmatism to aberrations of a higher order--Part II: examples].

Authors:  J Bühren; T Kohnen
Journal:  Ophthalmologe       Date:  2007-11       Impact factor: 1.059

2.  Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up.

Authors:  Iraklis Vastardis; Bojan Pajic; Richard H Greiner; Brigitte Pajic-Eggspuehler; Daniel M Aebersold
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

3.  [Treatment of severe recurrent symblepharopterygium: combined ipsilateral autologous limbus and homologous amniotic membrane transplantation].

Authors:  C Huchzermeyer; Z Gatzioufas; F E Kruse; B Seitz
Journal:  Ophthalmologe       Date:  2014-09       Impact factor: 1.059

4.  A comparative study of preoperative and postoperative changes in corneal astigmatism after pterygium excision by different techniques.

Authors:  Pragya Garg; Anshu Sahai; Mohd Abid Shamshad; Lokendra Tyagi; Yamini Singhal; Shalini Gupta
Journal:  Indian J Ophthalmol       Date:  2019-07       Impact factor: 1.848

5.  Astigmatic changes following pterygium removal: comparison of 5 different methods.

Authors:  Rana Altan-Yaycioglu; Cem Kucukerdonmez; Aylin Karalezli; Fatma Corak; Yonca A Akova
Journal:  Indian J Ophthalmol       Date:  2013-03       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.